Skip to main content

STEMPOINT CAPITAL LP

Position in MLYS — Mineralys Therapeutics, Inc.

CIK 1952142 NEW YORK, NY

Position in MLYS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$16,260,468
+$1,811,258 QoQ
Shares Held
602,686
+13.0% QoQ
Ownership
0.682%
of shares outstanding
% of Portfolio
2.80%
of 13F equity value
Holder Rank
#42
of 224 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in MLYS Over Time

Shares Held

Position Value (USD)

Derivatives in MLYS

reported options exposure · as of Mar 31, 2025
CallValue
$0
CallShares
0
PutValue
$93,750
PutShares
125,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names. MLYS ranks #8 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 MLYS
Mineralys Therapeutics, Inc.
This page
602,686 $16,260,468

All Filings in MLYS

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16,260,468 602,686
2026-03-31 $14,449,210 533,378
2025-12-31 $10,525,878 290,049
2025-09-30 $5,995,607 158,112
2025-06-30 $8,545,358 631,586
2025-03-31 $93,750 125,000
2024-12-31 $4,925,243 400,101